

Allergy Therapeutics gets US FDA approval for peanut vaccine trial


TRADING UPDATES: Mobile Streams wins deal; East Imperial revenue jumps


UK shareholder meetings calendar - next 7 days


EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger


(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive top-line results from its exploratory field study 'G309' to evaluate ...


Allergy Therapeutics shares jump on positive G309 trial results


EARNINGS UPDATES: Harbour Energy enters black; Fonix profit rises


IN BRIEF: Allergy Therapeutics cheers secondary endpoint results